This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1979:19:25-52.

doi: 10.1146/annurev.pa.19.040179.000325.

Correlation of pharmacological effects with plasma levels of antihypertensive drugs in man

PMID: 36827
DOI: 10.1146/annurev.pa.19.040179.000325

Review

Correlation of pharmacological effects with plasma levels of antihypertensive drugs in man

Z H Israili. Annu Rev Pharmacol Toxicol. 1979.

. 1979:19:25-52.

doi: 10.1146/annurev.pa.19.040179.000325.

Author

PMID: 36827
DOI: 10.1146/annurev.pa.19.040179.000325

No abstract available

PubMed Disclaimer

Similar articles

Use of sympatholytic and vasodilator drugs.
Moyer JH. Moyer JH. Pa Med. 1984 Jan;87(1):34-42. Pa Med. 1984. PMID: 6144088 No abstract available.
[Therapy of essential arterial hypertension. V].
Fossati C. Fossati C. Clin Ter. 1980 Jun 15;93(5):577-94. Clin Ter. 1980. PMID: 6107196 Review. Italian. No abstract available.
[Current treatment of hypertension].
Halawa B. Halawa B. Wiad Lek. 1980 Apr 1;33(8):625-30. Wiad Lek. 1980. PMID: 6105745 Review. Polish. No abstract available.
[Practical medical treatment of essential arterial hypertension].
Menard J, Corvol P, Bloch-Laine JF, Milliez P. Menard J, et al. Minerva Med. 1973 Oct 31;64(77):4051-8. Minerva Med. 1973. PMID: 4148729 Italian. No abstract available.
[Pharmacological basis of the symptomatic treatment of arterial hypertension. II. Antihypertensive agent combinations].
Fournier A, Lagrue G, Schmitt H. Fournier A, et al. Nouv Presse Med. 1973 Nov 3;2(39):2595-600. Nouv Presse Med. 1973. PMID: 4152250 French. No abstract available.

See all similar articles

Cited by

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
Wellstein A, Palm D, Pitschner HF, Belz GG. Wellstein A, et al. Eur J Clin Pharmacol. 1985;29(2):131-47. doi: 10.1007/BF00547412. Eur J Clin Pharmacol. 1985. PMID: 3000793 Clinical Trial.
Use of gene markers to guide antihypertensive therapy.
Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. Turner ST, et al. Curr Hypertens Rep. 2001 Oct;3(5):410-5. doi: 10.1007/s11906-001-0059-x. Curr Hypertens Rep. 2001. PMID: 11551376 Review.
Concentration-effect relationships for oxprenolol in patients with essential hypertension.
McInnes GT, Brodie MJ. McInnes GT, et al. Br J Clin Pharmacol. 1988 May;25(5):539-45. doi: 10.1111/j.1365-2125.1988.tb03343.x. Br J Clin Pharmacol. 1988. PMID: 3408634 Free PMC article. Clinical Trial.
Clinical pharmacokinetics of urapidil.
Kirsten R, Nelson K, Steinijans VW, Zech K, Haerlin R. Kirsten R, et al. Clin Pharmacokinet. 1988 Mar;14(3):129-40. doi: 10.2165/00003088-198814030-00001. Clin Pharmacokinet. 1988. PMID: 3286082 Review.
Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.
Kulkarni P, Korzekwa K, Nagar S. Kulkarni P, et al. J Pharmacol Exp Ther. 2016 Oct;359(1):26-36. doi: 10.1124/jpet.116.235689. Epub 2016 Jul 22. J Pharmacol Exp Ther. 2016. PMID: 27451408 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc